{"brief_title": "Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)", "brief_summary": "The purpose of this study is to assess the biological activity of ZD6126 in subjects with newly diagnosed metastatic renal cell carcinoma (stage IV).", "condition": ["Carcinoma, Renal Cell", "Kidney Neoplasms"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["ZD6126", "Placebo"], "criteria": "Inclusion Criteria: - Newly diagnosed metastatic renal cell carcinoma - Suitable for nephrectomy Exclusion Criteria: - Prior chemotherapy, biological therapy or radiation therapy for renal cell carcinoma or within the last 3 years for any other cancer - Significant cardiac event within 3 months of entry - Any history of coronary angioplasty or history of myocardial infarction", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Newly diagnosed renal cell carcinoma", "mesh_term": ["Carcinoma", "Carcinoma, Renal Cell", "Kidney Neoplasms"], "id": "NCT00065572"}